{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:57:57Z","timestamp":1793051877490,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaad.2026.02.056","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:02:30Z","timestamp":1771488150000},"page":"1848-1850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative hazards of ocular surface disorders with interleukin-4\/interleukin-13 versus interleukin-13 inhibitors in atopic dermatitis: A TriNetX database study"],"prefix":"10.1016","volume":"94","author":[{"given":"Yi-Hsuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Sheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0639-3533","authenticated-orcid":false,"given":"Teng-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2026.02.056_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ACI.0000000000000842","article-title":"Comparison of cytokine mediators in type 2 inflammatory conditions on the skin and ocular surface","volume":"22","author":"Chen","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.jaad.2026.02.056_bib2","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/all.15326","article-title":"IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro","volume":"77","author":"Hansen","year":"2022","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.jaad.2026.02.056_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/bjd\/ljae344","article-title":"An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024","volume":"191","author":"Ardern-Jones","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.02.056_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jdin.2023.05.014","article-title":"Incidence of conjunctivitis adverse event in patients treated with biologics for atopic dermatitis: a systematic review and meta-analysis","volume":"13","author":"Alraddadi","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaad.2026.02.056_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ijd.70027","article-title":"Incidence, risk factors, and management of conjunctivitis in atopic dermatitis patients treated with dupilumab or tralokinumab: results from a multicenter, observational, retrospective study","volume":"65","author":"Potestio","year":"2026","journal-title":"Int J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226002707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226002707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:07:41Z","timestamp":1779192461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226002707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0190962226002707"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.02.056","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative hazards of ocular surface disorders with interleukin-4\/interleukin-13 versus interleukin-13 inhibitors in atopic dermatitis: A TriNetX database study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.02.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}